National Health Investors, Inc. NHI
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 275.48M | 277.00M | 275.88M | 271.60M | 267.10M |
| Total Other Revenue | 181.93M | 156.77M | 127.23M | 106.10M | 88.88M |
| Total Revenue | 457.41M | 433.77M | 403.11M | 377.70M | 355.98M |
| Cost of Revenue | 132.30M | 112.22M | 87.70M | 70.50M | 58.11M |
| Gross Profit | 325.11M | 321.55M | 315.41M | 307.19M | 297.87M |
| SG&A Expenses | 34.09M | 31.48M | 29.44M | 29.53M | 27.75M |
| Depreciation & Amortization | 96.66M | 91.11M | 85.48M | 80.94M | 77.97M |
| Other Operating Expenses | 995.00K | 996.00K | 1.03M | 1.08M | 850.00K |
| Total Operating Expenses | 264.04M | 235.81M | 203.64M | 182.06M | 164.68M |
| Operating Income | 193.37M | 197.96M | 199.48M | 195.63M | 191.30M |
| Income Before Tax | 697.14M | 166.12M | 146.72M | 140.79M | 145.77M |
| Income Tax Expenses | 1.01M | 732.00K | -- | -- | -- |
| Earnings from Continuing Operations | 696.13 | 165.39 | 146.72 | 140.79 | 145.77 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 1.34M | 1.41M | 1.39M | 1.39M | 1.49M |
| Net Income | 697.46M | 166.80M | 148.11M | 142.18M | 147.26M |
| EBIT | 193.37M | 197.96M | 199.48M | 195.63M | 191.30M |
| EBITDA | 290.02M | 289.07M | 284.95M | 276.58M | 269.27M |
| EPS Basic | 14.25 | 3.47 | 3.11 | 3.03 | 3.19 |
| Normalized Basic EPS | 1.83 | 1.84 | 1.89 | 1.87 | 1.83 |
| EPS Diluted | 14.24 | 3.46 | 3.10 | 3.02 | 3.17 |
| Normalized Diluted EPS | 1.83 | 1.84 | 1.89 | 1.87 | 1.82 |
| Average Basic Shares Outstanding | 193.45M | 191.85M | 190.10M | 187.50M | 184.96M |
| Average Diluted Shares Outstanding | 193.97M | 192.55M | 190.88M | 188.21M | 185.76M |
| Dividend Per Share | 3.70 | 3.68 | 3.66 | 3.64 | 3.62 |
| Payout Ratio | 25.53% | 105.26% | 116.81% | 119.36% | 112.14% |